Cyalume Technologies (CYLU) 10-Q 16 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 12, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Entity Registrant Name	Cyalume Technologies Holdings, Inc.
Entity Central Index Key	1,335,293
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CYLU
Entity Common Stock, Shares Outstanding		21,400,244

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash	$ 1,631	$ 2,358
Accounts receivable, net of allowance for doubtful accounts of $7 and $22, respectively	4,307	3,622
Inventories, net	7,970	7,826
Income taxes refundable	213	0
Prepaid expenses and other current assets	2,034	648
Total current assets	16,155	14,454
Property, plant and equipment, net	6,858	7,120
Goodwill	7,992	7,992
Other intangible assets, net	5,908	6,591
Debt issue costs, noncurrent	854	0
Other noncurrent assets	0	18
Total assets	37,767	36,175
Current liabilities:
Line of credit	2,000	2,050
Current portion of notes payable	655	5,775
Accounts payable	1,349	2,144
Accrued expenses	3,202	2,690
Deferred revenue and deferred rent	180	181
Income taxes payable	464	644
Capital lease obligation	0	7
Warrants liability	18	25
Total current liabilities	7,868	13,516
Notes payable, net of current portion	16,388	10,214
Note payable due to related parties	0	2,100
Deferred income taxes	382	430
Legal obligation	0	2,781
Other noncurrent liabilities	284	282
Total liabilities	$ 24,922	$ 29,323
Commitments and contingencies (Note 12)
Stockholders' (deficit) equity:
Series B convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 1,000 shares issued and outstanding	$ 1,401	$ 1,401
Common stock, $0.001 par value; 150,000,000 shares authorized; 21,400,244 shares issued and outstanding	21	21
Additional paid-in capital	102,741	103,014
Accumulated deficit	(100,460)	(103,590)
Accumulated other comprehensive loss	(893)	(661)
Total stockholders’ equity	2,810	185
Total liabilities and stockholders' equity	37,767	36,175
Series C Preferred Stock [Member]
Temporary Equity
Temporary Equity	2,297	2,103
Series D Convertible Preferred Stock [Member]
Temporary Equity
Temporary Equity	2,751	0
Series A Convertible Preferred Stock [Member]
Temporary Equity
Temporary Equity	$ 4,987	$ 4,564

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Accounts receivable, allowance for doubtful accounts	$ 7	$ 22
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	21,400,244	21,400,244
Common stock, shares outstanding	21,400,244	21,400,244
Series A Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	123,097	123,097
Preferred stock, shares outstanding	123,097	123,097
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series B convertible preferred stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	10	10
Preferred stock, shares outstanding	10	10

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues	$ 10,541	$ 8,387	$ 27,399	$ 24,543
Cost of revenues	5,286	4,515	14,416	14,243
Gross profit	5,255	3,872	12,983	10,300
Other expenses (income):
Sales and marketing	559	966	1,667	2,831
General and administrative	2,049	1,641	5,535	5,114
Research and development	287	432	886	1,186
Interest expense, net	840	526	2,200	1,563
Interest expense - related party	0	68	100	291
Amortization of intangible assets	238	564	715	1,557
Legal settlement	0	0	(1,381)	0
Change in warrant liability fair value	(12)	197	(7)	(4,844)
Impairment loss on intangible assets	0	9,100	0	9,100
Loss on extinguishment of related party debt	0	527	0	527
Other expenses (income), net	(12)	12	(143)	363
Total other expenses, net	3,949	14,033	9,572	17,688
Income (loss) before income taxes	1,306	(10,161)	3,411	(7,388)
Provision for income taxes	162	112	281	287
Net income (loss)	1,144	(10,273)	3,130	(7,675)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	36	(246)	(232)	(298)
Other comprehensive income (loss)	36	(246)	(232)	(298)
Comprehensive income (loss)	1,180	(10,519)	2,898	(7,973)
Net income (loss)	1,144	(10,273)	3,130	(7,675)
Net income (loss) available to common stockholders - basic	931	(15,365)	2,514	(13,012)
Change in fair value of warrant liability	(12)	0	(7)	0
Convertible related party promissory note	0	0	45	0
Series A convertible preferred stock dividends	146	0	422	0
Net income (loss) available to common stockholders - diluted	$ 1,065	$ (15,365)	$ 2,974	$ (13,012)
Earnings (loss) per common share:
Basic	$ 0.04	$ (0.72)	$ 0.12	$ (0.61)
Diluted	$ 0.01	$ (0.72)	$ 0.03	$ (0.61)
Weighted average shares used to compute net earnings (loss) per common share:
Basic	21,400,244	21,400,244	21,400,244	21,258,011
Diluted	101,875,913	21,400,244	101,579,116	21,258,011
Series A Convertible Preferred Stock [Member]
Other comprehensive income (loss), net of tax:
Preferred stock dividends	$ (146)	$ (130)	$ (422)	$ (375)
Series C Preferred Stock [Member]
Other comprehensive income (loss), net of tax:
Preferred stock dividends	(67)	(41)	(194)	(41)
Series A Deemed Dividend [Member]
Other comprehensive income (loss), net of tax:
Preferred stock dividends	0	(2,422)	0	(2,422)
Series B Deemed Dividend [Member]
Other comprehensive income (loss), net of tax:
Preferred stock dividends	0	(1,098)	0	(1,098)
Series C Deemed Dividend [Member]
Other comprehensive income (loss), net of tax:
Preferred stock dividends	$ 0	$ (1,401)	$ 0	$ (1,401)

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Changes in Preferred Stock and Stockholders' Equity - 9 months ended Sep. 30, 2015 - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Preferred Stock [Member]Series A Convertible Preferred Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series D Convertible Preferred Stock [Member]	Preferred Stock [Member]Series B Preferred Stock [Member]
Balance at Dec. 31, 2014	$ 185	$ 21	$ 103,014	$ (103,590)	$ (661)	$ 4,564	$ 2,103	$ 0	$ 1,401
Balance (in shares) at Dec. 31, 2014		21,400,244				123,077	1,000	0	1,000
Dividends accrued on Series A and Series C preferred stock	(617)	$ 0	(617)	0	0	$ 423	$ 194	$ 0	$ 0
Issuance of Series A and Series D convertible preferred stock	0	$ 0	0	0	0	$ 0	$ 0	$ 2,751	$ 0
Issuance of Series A and Series D convertible preferred stock (in shares)		0				20	0	10	0
Relative fair value allocated to warrant issued	42	$ 0	42			$ 0	$ 0	$ 0	$ 0
Share-based compensation	302	$ 0	302	0	0	$ 0	$ 0	$ 0	$ 0
Share-based compensation (in shares)		0				0	0	0	0
Net income	3,130	$ 0	0	3,130	0	$ 0	$ 0	$ 0	$ 0
Other comprehensive loss	(232)	0	0	0	(232)	0	0	0	0
Balance at Sep. 30, 2015	$ 2,810	$ 21	$ 102,741	$ (100,460)	$ (893)	$ 4,987	$ 2,297	$ 2,751	$ 1,401
Balance (in shares) at Sep. 30, 2015		21,400,244				123,097	1,000	10	1,000

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income (loss)	$ 3,130	$ (7,675)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of property, plant and equipment	933	1,059
Amortization of intangible assets, debt issuance costs and debt discount	1,423	1,736
Non-cash interest expense	414	750
Share-based compensation expense	302	313
Impairment loss on intangible assets	0	9,100
Change in fair value of derivatives	(29)	0
Change in fair value of warrant liability	(7)	(4,844)
Legal settlement	(1,381)	0
Loss on extinguishment of debt - related party	0	527
Other non-cash expenses	7	54
Changes in operating assets and liabilities:
Accounts receivable	(149)	(161)
Inventories	(207)	1,568
Prepaid expenses and other current assets	(521)	290
Accounts payable and accrued liabilities	(278)	(1,662)
Accrued interest on note payable to related party	(504)	188
Deferred revenue and deferred rent	(1)	89
Income taxes payable	(377)	261
Net cash provided by operating activities	2,755	1,593
Cash flows from investing activities:
Purchases of long-lived assets	(778)	(302)
Payments for intangibles	(109)	(166)
Net cash used in investing activities	(887)	(468)
Cash flows from financing activities:
(Repayments on) proceeds from TD Bank line of credit, net	(2,050)	150
Principal repayments on CTI long term notes payable	(15,880)	(1,437)
Borrowings on Monroe line of credit, net	2,000	0
Borrowings on Monroe long term notes payable, net of repayments	19,266	0
Repayment of related party note payable	(2,100)	0
Principal payments on capital lease obligations	(7)	(11)
Proceeds from issuance of Series C and Series B preferred stock	0	2,000
Proceeds received from warrant exercise	0	1
Payment of preferred stock issuance costs	0	(321)
Payment in connection with legal settlement agreement	(1,615)	(1,465)
Payment of debt issuance and deferred financing costs	(2,118)	(21)
Net cash used in financing activities	(2,504)	(1,104)
Effect of exchange rate changes on cash	(91)	(38)
Net decrease in cash	(727)	(17)
Cash, beginning of period	2,358	865
Cash, end of period	$ 1,631	$ 848

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	1. ORGANIZATION Cyalume Technologies Holdings, Inc. (the “Company”) was organized as a blank check company under the laws of the State of Delaware on July 19, 2005. At that time, the Company was named Vector Security Intersect Acquisition Corp. On December 19, 2008, the Company acquired Cyalume Technologies, Inc. (“CTI”) and changed the corporate name to the current name. CTI is a Delaware corporation formed on March 27, 1997 with headquarters located in Fort Lauderdale, Florida.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. All the adjustments which, in the opinion of management, are considered necessary for a fair presentation of the results of operations for the periods shown are of a normal recurring nature and have been reflected in the unaudited condensed consolidated financial statements. Results from operations for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2015. The consolidated balance sheet at December 31, 2014 has been derived from the audited consolidated financial statements at that date. The information included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended December 31, 2014 filed on March 31, 2015. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. While the Company believes that such estimates are fair when considered in conjunction with the condensed consolidated financial position and results of operations taken as a whole, the actual amount of such estimates, when known, may vary from these estimates.

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	9 Months Ended
	Sep. 30, 2015
Business Combination, Description [Abstract]
DESCRIPTION OF BUSINESS	3. DESCRIPTION OF BUSINESS These consolidated financial statements and footnotes include the financial position and operations of Cyalume Technologies Holdings, Inc. (“Cyalume”), a holding company that is the sole shareholder of Cyalume Technologies, Inc. (“CTI”), of Cyalume Specialty Products, Inc. (“CSP”) and of CT SAS Holdings, Inc. (“CT SAS Holdings”). CTI is the sole shareholder Cyalume Realty, Inc. (“CRI”) and Combat Training Solutions, Inc. (“CTS”) and CT SAS Holdings is the sole shareholder of Cyalume Technologies, SAS (“CTSAS”). All significant intercompany accounts and transactions have been eliminated in consolidation. The Company’s primary focus is providing tactical and training solutions to the military of the U.S. and other countries through both products and services. CTI and CTSAS manufacture and sell chemiluminescent products and reflective and photoluminescent materials to military, ammunition, commercial and public safety markets. CTSAS is located in France and represents us in certain international markets, primarily Europe and the Middle East. CTI sells to customers in all other geographic markets. CTI’s and CTSAS’s business operations constitute the majority, based on revenues and assets, of our consolidated business operations. CSP manufactures and sells specialty chemical products to the defense, pharmaceutical, cosmetic and other markets. CSP’s operations are located in Bound Brook, New Jersey. CRI previously owned land located in Colorado Springs, Colorado. The land was transferred in connection with a 2013 legal settlement. CTS provides its customers with battlefield effects simulation products while its services include planning and implementing tactical training exercises simulating real-world experiences. These products allow military and law enforcement professionals to maintain operational readiness through safe, live training and hands-on situational exercises. The Company’s business is managed and financial results are reported as one segment. Our CEO, who is the Company’s chief operating decision maker, focuses on consolidated results to make strategic and tactical decisions. The Company’s one operating segment consists of three reporting units: Chemical Light (the operations of CTI, CTS and CTSAS), Specialty Products (the operations of CSP) and Other (the operations of CRI, the holding company CT SAS Holdings and the parent company Cyalume Technologies Holdings, Inc.). The Company’s condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the nine months ended September 30, 2015, the Company had net income of approximately $ 3.1 2.8 100.5 2.8 1.6 Due to uncertainty about the Company’s ability to meet its current debt obligations, in their report on our annual financial statements for the year ended December 31, 2014, the Company’s independent registered public accounting firm included an explanatory paragraph regarding the Company’s ability to continue as a going concern. Management continues to evaluate various possibilities including but not limited to refinancing or restructuring the Company’s debt, reducing or eliminating operating expenses, and raising additional capital through the issuance of common or preferred stock or securities convertible into common stock. Effective May 18, 2015, the Company refinanced the majority of its debt (see Note 6). Should additional financial support be required in the future, there can be no assurances that the Company will be successful in raising adequate additional financial support. If unable to do so, the Company could be required to reduce operations. The Company’s condensed consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
INVENTORIES	4. INVENTORIES September 30, December 31, 2015 2014 Raw materials $ 4,702 $ 4,777 Work-in-process 1,833 1,546 Finished goods 1,435 1,503 $ 7,970 $ 7,826

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	5. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instrument Balance Sheet Location Fair Value Currency forward contract Other current assets $ 0 Warrants Warrant liability (18) (See Note 8) Currency Forward Contracts CTSAS’ functional currency is the Euro. Periodically, CTSAS purchases inventory from CTI, which requires payment in U.S. dollars. Under certain circumstances, the Company uses currency forward contracts to mitigate CTSAS’ exposure to changes in the Euro-to-U.S. dollar exchange rate upon payment of these inventory purchases. Such currency forward contracts typically have durations of less than six months. The Company reports these currency forward contracts at their fair value. This relationship has not been designated as a hedge and therefore all changes in these currency forward contracts’ fair value are recorded in other (income) expenses, net within the accompanying condensed consolidated statements of comprehensive income. At September 30, 2015, the Company did not have any currency forward contracts outstanding. See Note 13 for a description of how the fair v alue of forward contracts is est

CREDIT LINE AND NOTES PAYABLE

CREDIT LINE AND NOTES PAYABLE	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
CREDIT LINE AND NOTES PAYABLE	6. CREDIT LINE AND NOTES PAYABLE Monroe Refinancing On May 18, 2015, the Company entered into a credit agreement with Monroe Capital Management Advisors, LLC (the “Monroe Credit Agreement”), refinancing its existing senior and subordinated debt (see below). The Monroe Credit Agreement provides for a $ 25.0 5.0 18.0 2.0 The Monroe Credit Agreement has a term of five years and bears 113,000 225,000 450,000 11.3 Pursuant to the terms of the Monroe Credit Agreement, the Company must maintain: (i) a fixed charge coverage ratio of 1.25 to 1.00; (ii) a senior debt to EBITDA ratio of 4.50 to 1.00, decreasing to 1.50 to 1.00 over the term of the loans; and (iii) a twelve month trailing EBITDA, measured quarterly, in the amount of $4,750,000, increasing to $7.0 million over the term of the loans On August 3, 2015, the Company entered into a First Amendment (the “First Amendment”) to the Monroe Credit Agreement. Pursuant to the First Amendment, the Monroe Credit Agreement was amended to, among other things, reduce the aggregate amount of the Delayed Draw Loan under the Monroe Credit Agreement, which loan commitment was for purposes of funding the final payment due under the Settlement Agreement, from $ 2.0 1.5 1.4 100,000 The Delayed Draw Loan, which was drawn on August 3, 2015 (see Note 12), provides for quarterly amortization payments on the last day of each calendar quarter in an aggregate principal amount equal to 0.625% of the original principal amount of the Delayed Draw Loan, increasing to 1.25% on March 31, 2016, and increasing to 2.5% on March 31, 2017, with the balance payable on the maturity date of May 18, 2020. In connection with the execution of the Monroe Credit Agreement, the Company issued 10 The proceeds from the Monroe Credit Agreement were allocated to the various instruments issued based on their relative fair value. Line of Credit The Monroe Line of Credit has a maximum borrowing capacity of $ 5.0 10 2.0 2.9 Notes Payable September 30, December 31, 2015 2014 Monroe Term A Loan $ 17,775 $ 0 Delayed Draw Loan 1,491 0 TD Bank Term Loan 0 4,239 TD Bank Real Estate Loan 0 1,551 Subordinated Term Loan 0 9,676 Promissory Note Payable 645 860 Total 19,911 16,326 Less: Unamortized debt discount (2,868) (337) Less: Current portion of notes payable, including current portion of unamortized debt discount (655) (5,775) Notes payable, net of current portion $ 16,388 $ 10,214 Term Loans In addition to the previous line of credit with TD Bank, CTI previously had two loans payable to TD Bank, a Term Loan and a Real Estate Loan (together, the “Senior Debt”), that were originally entered into on December 19, 2008, and which were amended twice during 2012 to modify certain financial and non-financial covenants required by these loans. The Fourth Amendment to the Amended and Restated Revolving Credit and Term Loan Agreement (the “Senior Amendment”) was entered into on November 19, 2013. On July 29, 2010, the subordinated term loan of $ 8.5 June 30, 2016 11 2,666,667 3.19 160,000 1.50 0.01 455,514 June 30, 2016 455,514 18,000 The Company’s Senior Debt and Subordinated Term Loan were refinanced on May 18, 2015. Upon the consummation of the Monroe Credit Agreement, the Company paid in full all amounts due under (i) the Amended and Restated Revolving Credit and Term Loan Agreement, dated July 29, 2010, as amended (the “Senior Credit Agreement”), by and among the Company, Cyalume Technologies, Inc. (“CTI”), certain of the Company’s other subsidiaries and TD Bank, N.A., as administrative agent and lender, (ii) the Subordinated Term Loan, dated July 29, 2010, as amended (the “Subordinated Loan Agreement”), by and among the Company, CTI, certain of the Company’s other subsidiaries, Granite Creek Flexcap I, L.P., Patriot Capital II, L.P. and Granite Creek Partners Agent, L.L.C., as administrative agent, and (iii) the amended and restated promissory note, dated November 19, 2013, as amended, previously issued by the Company to JFC Technologies, LLC (the “Amended JFC Note”) (see Note 10), such that each of the Senior Credit Agreement, the Subordinated Loan Agreement and the Amended JFC Note was paid in full and the Company has no further financial obligations thereunder. At the time of the refinancing, the Company expensed the remaining unamortized issuance costs relating to the previous Senior Debt and Subordinated Term Loan of approximately $ 0.3 Promissory Note Payable On November 19, 2013, the Company entered into a legal settlement agreement. The executed settlement agreement provided for the Company to make a series of payments to Antonio Colon in the amount of $ 215,000 1,075,000 2

PREFERRED STOCK

PREFERRED STOCK	9 Months Ended
	Sep. 30, 2015
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
PREFERRED STOCK	7. PREFERRED STOCK Series A Convertible Preferred Stock The Company is authorized to issue 1,000,000 On November 19, 2013, the Company entered into a Securities Purchase Agreement (the “Series A Purchase Agreement”) with US VC Partners, L.P. (the “Series A Investor”) for the purchase by the Investor of 123,077 4.0 32.50 0.001 Each share of Series A Preferred Stock may be converted at any time at the option of the holder into a number of shares of common stock initially equal to 50 applicable conversion price per share of Series A Preferred Stock. The initial conversion price was equal to $ 0.65 0.13664587 Upon voluntary or involuntary liquidation, dissolution or winding up of the Company, each holder of Series A Preferred Stock is entitled to a liquidation preference of $ 32.50 Dividends on the Series A Preferred Stock accrue (payable in cash or in kind), whether or not declared by the Board and whether or not funds are available for the payment of dividends, at a rate of 12 Each share of Series A Preferred Stock will be entitled to a number of votes equal to the number of shares of common stock into which such share is convertible and shall be entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration. The requisite holders of the Series A Preferred Stock will have the right to cause the Company to redeem, out of funds legally available, all but not less than all of the then outstanding shares of Series A Preferred Stock, for a price per share equal to the Series A Liquidation Value of such shares from and after the fifth anniversary of the closing date of the Series A Purchase Agreement. Additionally, the Company will have the right to redeem all of the outstanding shares of Series A Preferred Stock from and after the eighth anniversary of the closing date of the Series A Purchase Agreement at a redemption price equal to the Series A Liquidation Value. As a result of the redemption provisions, the Series A Preferred Stock has been classified outside of permanent equity. Series B Convertible Preferred Stock On July 30, 2014, the Company entered into a Securities Purchase Agreement (the “Series B and C Purchase Agreement”) with Cova Small Cap Holdings, LLC (“Cova”), Bayonet Capital Fund I, LLC, and another investor (each, an “Investor”) for the purchase by the Investors of an aggregate of 1,000 2.0 2,000 0.001 0.001 1.3 Civil Action No. 06-706 The shares of Series B Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series B Convertible Preferred Stock, which was amended on May 15, 2015 (the “Amended Series B Certificate of Designation”). Pursuant to the Amended Series B Certificate of Designation, each share of Series B Preferred Stock ranks senior to the Company’s common stock (the “Common Stock”) and the Company’s Series A Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Amended Series B Certificate of Designation), each share of Series B Preferred Stock would be entitled to a liquidation preference in an amount equal to the amount per share that would have been payable had all shares of Series B Preferred Stock been converted into Common Stock immediately prior to such event in accordance with the terms of the Amended Series B Certificate of Designation, excluding for purposes of such calculation the liquidation preference payable to the holders of Series A Preferred Stock. Holders of the Series B Preferred Stock are entitled to convert at any time all or any portion of the shares of Series B Preferred Stock into a number of shares of Common Stock initially equal to 35,713.147 shares of Common Stock per share of Series B Preferred Stock (the “Conversion Number”). The Conversion Number is subject to customary adjustments, including for dividends, stock splits and other reorganizations affecting the Common Stock. In addition, the Conversion Number is subject to anti-dilution protections, subject to certain exceptions, if the Company issues or sells shares of Common Stock or other equity securities for no consideration or for consideration that is based on an equity valuation of the Company of less than $2.0 million in the aggregate (a “Trigger Issuance”). In the event of a Trigger Issuance, the Conversion Number shall be increased as of the close of business on the effective date of the Trigger Issuance to a number calculated as follows: (i) two-thirds of the Common Stock deemed Outstanding (as defined in the Amended Series A Certificate of Designation) immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000. Each share of Series B Preferred Stock will automatically convert into shares of Common Stock on the tenth anniversary of its original issuance date, at the then-current Conversion Number. Series C Preferred Stock The shares of Series C Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series C Preferred Stock, which was amended on May 15, 2015 (the “Amended Series C Certificate of Designation”). Pursuant to the Amended Series C Certificate of Designation, each share of Series C Preferred Stock ranks senior to the Common Stock, the Series A Preferred Stock, the Series B Preferred Stock and the Series D Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Amended Series C Certificate of Designation), each share of Series C Preferred Stock would be entitled to a liquidation preference equal to the sum of: (1) $3,000 per share (the “Base Liquidation Value”) and the (2) the amount, if any, by which the Base Value exceeds 150% of the purchase price (the “Excess Liquidation Value), plus any accrued but unpaid dividends, in each case subject to customary adjustments as set forth in the Amended Series C Certificate of Designation 12 2,000 75 Series D Convertible Preferred Stock In connection with the execution of the Monroe Credit Agreement, the Company entered into a Subscription Agreement (the “Subscription Agreement”) with Monroe Capital Corporation, Monroe Capital Senior Secured Direct Loan Fund LP, Monroe Capital Senior Secured Direct Loan Fund (Unleveraged) LP and Monroe Capital Partners Fund II, LP. Pursuant to the Subscription Agreement, the Company issued 10 0.001 During the third quarter of 2015, the Company finalized the valuation of its Series D Convertible Preferred Stock. As described above, the Company issued 10 1.9 1.5 0.4 In the event of any voluntary or involuntary liquidation, the holders of the Series D Convertible Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to its stockholders before any payment shall be made to the holders of junior securities. The Series C Preferred Stockholders would receive the Base Liquidation Value first, and not be entitled to the Excess Liquidation Value (as defined in the Amended Certificate of Designation of the Series C Preferred Stock) until the holders of the Series D Convertible Preferred Stock receive a pro rata Liquidation Value amount in cash. If at any time the Company redeems the outstanding shares of Series A Preferred Stock or Series C Preferred Stock, the holders of the Series D Preferred Stock would have the right to elect to cause the Company to redeem, out of funds legally available therefore, all but not less than all of the then outstanding shares of Series D Preferred Stock, for a price per share equal to the Liquidation Value for such shares; provided that, prior to the Company paying the full redemption price for all outstanding shares of Series D Preferred Stock, the Company would not be permitted to pay (i) any amounts in excess of the Series C Base Liquidation Value upon the redemption of shares of Series C Preferred Stock or (ii) any amounts upon the redemption of shares of Series A Preferred Stock. In the event of a voluntary or involuntary liquidation, each share of Series D Preferred Stock would be entitled to a liquidation preference in an amount equal to the amount per share that would have been payable had all shares of Series D Preferred Stock been converted into Common Stock immediately prior to such event in accordance with the terms of the Series D Certificate of Designation, excluding for purposes of such calculation the liquidation preference payable to the holders of Series A Preferred Stock and the holders of Series B Preferred Stock. The Series D Preferred Stock does not have any voting rights, except that the written consent of the holders of a majority of the then-outstanding Series D Preferred Stock shall be required for the Company to take certain actions, including the amendment of its certificate of incorporation or bylaws in a manner that adversely affects the relative rights, preferences, privileges or powers of holders of Series D Preferred Stock. As a result of the redemption provisions, the Series D Convertible Preferred Stock has been classified outside of permanent equity.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	8. STOCKHOLDERS’ EQUITY Common Stock The Company is authorized to issue 150,000,000 Common and Preferred Warrants Common stock purchase warrants accounted for within equity are recorded at their initial fair value and reported in stockholders’ equity as increases to additional paid-in capital. Warrants reported as equity, rather than liabilities (i) may not be net-cash settled, (ii) have contractual limits on the number of shares to be delivered in a net-share settlement and (iii) are supported by sufficient unissued common shares available to settle the outstanding warrants. Subsequent changes in fair value from the warrants’ initial fair value are not recognized as long as the warrants continue to merit classification as equity. During 2012, warrants to purchase 160,000 455,514 Pursuant to the terms of a letter agreement previously entered into between the Company and Dragonfly Capital Partners, LLC (“Dragonfly”) under which Dragonfly provided advisory services to the Company in connection with the Company’s debt financing, the Company paid $ 820,000 1,003,744 0.05 The estimated fair value of the Dragonfly Warrant was recorded as an issuance cost in connection with the Monroe refinancing transaction. 46,000 Stock price of underlying equity $ 0.05 Exercise price $ 0.05 Expected term (years) 5.0 Risk-free interest rate 1.5 % Estimated dividend yield None Volatility 157.0 % The Dragonfly Warrant was reflected at its relative fair value of approximately $ 42,000 Number of Number of Shares Shares Exercisable Under Under Exercise Warrant Holder Warrant Warrant Price Expiration Date Granite Creek FlexCap I, L.P. (“Granite”) 267,950 267,950 $ 0.01 November 19, 2023 Patriot Capital II, L.P. (“Patriot”) 187,564 187,564 $ 0.01 November 19, 2023 Dragonfly Capital Partners, LLC (“Dragonfly”) 1,003,744 1,003,744 $ 0.05 May 18, 2020 Granite and Patriot Warrants Stock price of underlying equity $ 0.04 Exercise price $ 0.01 Expected term (years) 8.1 Risk-free interest rate 1.9 % Estimated dividend yield None Volatility 165.2 % Granite and Patriot Warrants (see Note 6) Warrant liability at December 31, 2014 $ 25 Change in fair value of warrants (7) Warrant liability at September 30, 2015 $ 18

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	9. INCOME TAXES During the nine months ended September 30, 2015, the Company recorded approximately $ 211,000 70,000 269,000 13.1

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTION	10. RELATED PARTY TRANSACTIONS Financing Arrangements with Related Parties In December 2012, the Company entered into a $ 2,100,000 12 Amended JFC Note of approximately $ 2.1 0.5 1.0 32.50 650 20 CSP leases property in Bound Brook, New Jersey, from Brook Industrial Park, LLC. This lease requires monthly lease payments of approximately $ 30,000 August 31, 2016 Bayonet Capital Fund I, LLC, Brook Industrial Park, LLC and JFC are controlled by James Schleck.

NET INCOME (LOSS) PER COMMON SH

NET INCOME (LOSS) PER COMMON SHARE	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
NET LOSS PER COMMON SHARE	11. NET INCOME (LOSS) PER COMMON SHARE Basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the basic weighted average number of common shares outstanding. Diluted income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares and dilutive potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible notes and convertible preferred stock using the “if-converted” method. Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator (in thousands): Net income (loss) $ 1,144 $ (10,273) $ 3,130 $ (7,675) Less: Series A convertible preferred stock dividends (146) (130) (422) (375) Less: Series C preferred stock dividends (67) (41) (194) (41) Less: Series A deemed dividend 0 (2,422) 0 (2,422) Less: Series B deemed dividend 0 (1,098) 0 (1,098) Less: Series C deemed dividend 0 (1,401) 0 (1,401) Income (loss) available to common stockholders - basic $ 931 $ (15,365) $ 2,514 $ (13,012) Effect of dilutive securities: Less: Change in fair value of warrant liability for dilutive warrants (income) expense (12) 0 (7) 0 Add: Convertible related party promissory note 0 0 45 0 Add: Series A convertible preferred stock dividends 146 0 422 0 Income (loss) available to common stockholders - diluted $ 1,065 $ (15,365) $ 2,974 $ (13,012) Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Denominator: Weighted average shares outstanding - basic 21,400,244 21,400,244 21,400,244 21,258,011 Effect of dilutive securities: Warrants 744,256 0 581,133 0 Series B convertible preferred stock 35,713,147 0 35,713,147 0 Series D convertible preferred stock 7,528,078 0 3,695,101 0 Convertible related party promissory note 0 0 3,699,303 0 Series A convertible preferred stock 36,490,188 0 36,490,188 0 Convertible debt 0 0 0 0 Weighted average common shares - diluted 101,875,913 21,400,244 101,579,116 21,258,011 Income (loss) per common share: Basic $ 0.04 $ (0.72) $ 0.12 $ (0.61) Diluted $ 0.01 $ (0.72) $ 0.03 $ (0.61) The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Options 10,505,322 2,636,186 10,505,322 2,636,186 Series A convertible preferred stock 0 32,421,014 0 32,421,014 Series B convertible preferred stock 0 35,713,147 0 35,713,147 Convertible related party promissory note 0 7,318,187 0 7,318,187 Convertible debt 0 2,666,667 0 2,666,667 Warrants 0 455,514 0 455,514

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Legal Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts On January 23, 2006, before the Company owned CTI, the former owners of CTI (from whom CTI was purchased) (the “Former Owners”) acquired all of the outstanding capital stock of Omniglow Corporation (the “Transaction”) and changed the name of the company to Cyalume Technologies, Inc. Prior to, or substantially simultaneously with, the Transaction, CTI sold certain assets and liabilities related to Omniglow Corporation’s novelty and retail business to certain former Omniglow Corporation stockholders and management (“the Omniglow Buyers”). This was done because CTI sought to retain only the Omniglow Corporation assets and current liabilities associated with its government, military and safety business. During 2006, CTI and the Omniglow Buyers commenced litigation and arbitration proceedings against one another. Claims include breaches of a lease and breaches of various other agreements between CTI and the Omniglow Buyers. These proceedings are known as Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts (the “Court”). On December 19, 2008, while Civil Action 06-706 was still unresolved, the Company acquired CTI (the “Acquisition”). According to the Stock Purchase Agreement between the Former Owners and the Company, the Former Owners retained the responsibility for paying for all costs and liabilities associated with Civil Action No. 06-706. On July 18, 2011, CTI received an Order for Entry of Final Judgment in Civil Action No. 06-706 in which the Court awarded approximately $ 2.6 12 1.3 235,000 12 On July 12, 2012, the Court issued an Amended Final Judgment and, on September 20, 2012, a Final Judgment. There were no changes to the previously described damage awards. In response, on October 17, 2012, the Company filed a Notice of Appeal and on August 2, 2013, the Company filed a Formal Appeal, which contains a number of bases for overturning the awards. Oral arguments were made by the parties before the Appellate Court during January of 2014. In May 2014, the Company received notice that its appeal of the Final Judgment had been denied. On July 1, 2014, CTI filed an Application for Further Appellate Review in the Massachusetts Supreme Judicial Court. The Former Owners (1) previously retained the responsibility for paying the costs and liabilities associated with Civil Action No. 06-706 and (2) are related parties under U.S. GAAP due to their ownership interest in the Company and their membership on the Company’s board of directors. On November 19, 2013, a Release and Escrow Agreement was executed whereby the Company released affiliates of the Former Owners from being obligated on the costs and liabilities associated with Civil Action No. 06-706 in exchange for 625,139 Shares provided the Company with a source of recovery with respect to any loss, liability or expenses incurred by the Company in connection with Civil Action No. 06-706. The Company reflected the value of the 625,139 Escrowed Shares at each reporting period based upon the close price of Cyalume’s stock at each balance sheet date. The Escrow Shares were transferred during July 2014 in connection with the Confidential Settlement Agreement and Mutual Release discussed below. On July 10, 2014, the Company entered into a Confidential Settlement Agreement and Mutual Release (the “Omniglow Settlement Agreement”) with the Former Owners and members of management of Omniglow Corporation (collectively, the “Omniglow Buyers”). Pursuant to the Omniglow Settlement Agreement, CTI agreed to either pay the full settlement amount of approximately $4.5 million or satisfy the settlement amount as follows: (i) an initial payment of $250,000, (ii) transfer the 625,139 Escrowed Shares, (iii) payment of $1.0 million in cash within 21 days from the execution of the Omniglow Settlement Agreement and (iv) additional payments in cash and/or through cooperative marketing credits of $1.9 million if paid within 18 months from the date of the Omniglow Settlement Agreement, or of approximately $2.4 million if paid within 27 months from the date of the Omniglow Settlement Agreement During 2015, CTI entered into a Second Amendment (the “Settlement Amendment”) to the Confidential and Mutual Release (the “Settlement Agreement”) which was initially entered into on July 10, 2014 (as described above), with certain former stockholders and members of management of Omniglow Corporation (collectively, the “Omniglow Buyers”). Pursuant to the Settlement Amendment, CTI’s obligation was reduced and a final payment of $ 1.4 1.9 2.35 1,381,000 1.4

FAIR VALUES OF ASSETS AND LIABI

FAIR VALUES OF ASSETS AND LIABILITIES	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
FAIR VALUES OF ASSETS AND LIABILITIES	13. FAIR VALUES OF ASSETS AND LIABILITIES Under U.S. GAAP, the Company is required to record certain financial assets and liabilities at fair value and may choose to record other financial assets and financial liabilities at fair value as well. Also under U.S. GAAP, the Company is required to record nonfinancial assets and liabilities at fair value due to events that may or may not recur in the future, such as an impairment event. When we are required to record such assets and liabilities at fair value, that fair value is estimated using an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. That fair value is determined based on significant inputs contained in a fair value hierarchy as follows: Level 1 Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date. Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 Unobservable inputs for the asset or liability. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement. There are three general valuation techniques that may be used to measure fair value, as described below: Market Approach Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Prices may be indicated by pricing guides, sale transactions, market trades, or other sources. Cost Approach Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). Income Approach Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (includes present value techniques and option-pricing models). Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate. Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities itemized below were measured at fair value on a recurring basis at September 30, 2015 (all amounts in thousands): Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (18) (18) $ 0 $ 0 $ (18) $ (18) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2014 (all amounts in thousands): Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (25) (25) $ 0 $ 0 $ (25) $ (25) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model (See Note 8 for assumptions) The Company did not transfer any assets or liabilities between Levels 1, 2 or 3 during the three months ended September 30, 2015. Any such transfer would be based on a review of the inputs used that are significant to the fair value measurement of that asset or liability. The Company has other financial instruments, such as cash, accounts receivable, other current assets, accounts payable, notes payable and a line of credit. The Company believes the carrying amounts of those assets and liabilities approximate their fair value since the Company has estimated those carrying amounts to approximate the exit price we would receive to sell these assets or pay to transfer these liabilities to a market participant. Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis During the three and nine months ended September 30, 2015, none of our assets or liabilities were remeasured at fair value on a nonrecurring basis.

SUPPLEMENTAL DISCLOSURE OF CASH

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	9 Months Ended
	Sep. 30, 2015
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	14. SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash Paid for Interest and Income Taxes (all amounts in thousands): Nine Months Ended September 30, 2015 2014 Interest $ 1,019 $ 456 Income taxes 655 171 (all amounts in thousands): Nine Months Ended September 30, 2015 2014 Series A Convertible Preferred stock accrued dividend $ 422 $ 375 Series C Preferred stock accrued dividend 194 41 Issuance of Series D Convertible Preferred stock in connection with debt refinancing 2,751 0 Relative fair value of warrant issued in connection with debt refinancing 42 0 Adjustment to warrant liability upon warrant exercise 0 44 Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP 0 241 Issuance of 242,308 shares to Selway 0 157

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Sep. 30, 2015
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	15. NEW ACCOUNTING PRONOUNCEMENTS The following are recent accounting pronouncements that have affected our consolidated financial statements or may affect them in the future. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern (Topic 915): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In April 2015, the FASB issued ASU 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consist of the following (all amounts in thousands): September 30, December 31, 2015 2014 Raw materials $ 4,702 $ 4,777 Work-in-process 1,833 1,546 Finished goods 1,435 1,503 $ 7,970 $ 7,826

DERIVATIVE INSTRUMENTS AND HE23

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Assets in Condensed Consolidated Balance Sheet	The derivative assets and (liabilities) as of September 30, 2015 in our condensed consolidated balance sheet consist of the following (all amounts in thousands): Derivative Instrument Balance Sheet Location Fair Value Currency forward contract Other current assets $ 0 Warrants Warrant liability (18) (See Note 8)

CREDIT LINE AND NOTES PAYABLE (

CREDIT LINE AND NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt	Outstanding notes payable consist of (all amounts in thousands): September 30, December 31, 2015 2014 Monroe Term A Loan $ 17,775 $ 0 Delayed Draw Loan 1,491 0 TD Bank Term Loan 0 4,239 TD Bank Real Estate Loan 0 1,551 Subordinated Term Loan 0 9,676 Promissory Note Payable 645 860 Total 19,911 16,326 Less: Unamortized debt discount (2,868) (337) Less: Current portion of notes payable, including current portion of unamortized debt discount (655) (5,775) Notes payable, net of current portion $ 16,388 $ 10,214

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	9 Months Ended
	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Stockholders Equity Note, Warrants or Rights	Warrants to purchase the Company’s common stock were outstanding as follows as of September 30, 2015: Number of Number of Shares Shares Exercisable Under Under Exercise Warrant Holder Warrant Warrant Price Expiration Date Granite Creek FlexCap I, L.P. (“Granite”) 267,950 267,950 $ 0.01 November 19, 2023 Patriot Capital II, L.P. (“Patriot”) 187,564 187,564 $ 0.01 November 19, 2023 Dragonfly Capital Partners, LLC (“Dragonfly”) 1,003,744 1,003,744 $ 0.05 May 18, 2020
Schedule Of Change In The Fair Value Of The Warrants Liability	The change in the fair value of the warrants liability during the nine months ended September 30, 2015 is as follows (amounts in thousands): Granite and Patriot Warrants (see Note 6) Warrant liability at December 31, 2014 $ 25 Change in fair value of warrants (7) Warrant liability at September 30, 2015 $ 18
Dragonfly Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The Dragonfly Warrant fair value of approximately $ 46,000 Stock price of underlying equity $ 0.05 Exercise price $ 0.05 Expected term (years) 5.0 Risk-free interest rate 1.5 % Estimated dividend yield None Volatility 157.0 %
Granite and Patriot Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value as of September 30, 2015 of the Granite and Patriot Warrants is estimated using the Black-Scholes pricing model with the following inputs: Granite and Patriot Warrants Stock price of underlying equity $ 0.04 Exercise price $ 0.01 Expected term (years) 8.1 Risk-free interest rate 1.9 % Estimated dividend yield None Volatility 165.2 %

NET INCOME (LOSS) PER COMMON 26

NET INCOME (LOSS) PER COMMON SHARE (Tables)	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Net Income Per Common Share	Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Numerator (in thousands): Net income (loss) $ 1,144 $ (10,273) $ 3,130 $ (7,675) Less: Series A convertible preferred stock dividends (146) (130) (422) (375) Less: Series C preferred stock dividends (67) (41) (194) (41) Less: Series A deemed dividend 0 (2,422) 0 (2,422) Less: Series B deemed dividend 0 (1,098) 0 (1,098) Less: Series C deemed dividend 0 (1,401) 0 (1,401) Income (loss) available to common stockholders - basic $ 931 $ (15,365) $ 2,514 $ (13,012) Effect of dilutive securities: Less: Change in fair value of warrant liability for dilutive warrants (income) expense (12) 0 (7) 0 Add: Convertible related party promissory note 0 0 45 0 Add: Series A convertible preferred stock dividends 146 0 422 0 Income (loss) available to common stockholders - diluted $ 1,065 $ (15,365) $ 2,974 $ (13,012) Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Denominator: Weighted average shares outstanding - basic 21,400,244 21,400,244 21,400,244 21,258,011 Effect of dilutive securities: Warrants 744,256 0 581,133 0 Series B convertible preferred stock 35,713,147 0 35,713,147 0 Series D convertible preferred stock 7,528,078 0 3,695,101 0 Convertible related party promissory note 0 0 3,699,303 0 Series A convertible preferred stock 36,490,188 0 36,490,188 0 Convertible debt 0 0 0 0 Weighted average common shares - diluted 101,875,913 21,400,244 101,579,116 21,258,011 Income (loss) per common share: Basic $ 0.04 $ (0.72) $ 0.12 $ (0.61) Diluted $ 0.01 $ (0.72) $ 0.03 $ (0.61)
Common Shares Issuable upon Vesting or Exercise of Convertible Securities	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented: Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Options 10,505,322 2,636,186 10,505,322 2,636,186 Series A convertible preferred stock 0 32,421,014 0 32,421,014 Series B convertible preferred stock 0 35,713,147 0 35,713,147 Convertible related party promissory note 0 7,318,187 0 7,318,187 Convertible debt 0 2,666,667 0 2,666,667 Warrants 0 455,514 0 455,514

FAIR VALUES OF ASSETS AND LIA27

FAIR VALUES OF ASSETS AND LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities itemized below were measured at fair value on a recurring basis at September 30, 2015 (all amounts in thousands): Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (18) (18) $ 0 $ 0 $ (18) $ (18) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2014 (all amounts in thousands): Level 1 Quoted Prices in Active Level 2 Markets Significant Level 3 Assets/ for Other Significant (Liabilities) Identical Observable Unobservable At Fair Assets Inputs Inputs Value Warrants (see Note 8) (1) 0 0 (25) (25) $ 0 $ 0 $ (25) $ (25) (1) The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model (See Note 8 for assumptions)

SUPPLEMENTAL DISCLOSURE OF CA28

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2015
Supplemental Cash Flow Elements [Abstract]
Cash Paid for Interest and Income Taxes	Cash Paid for Interest and Income Taxes (all amounts in thousands): Nine Months Ended September 30, 2015 2014 Interest $ 1,019 $ 456 Income taxes 655 171
Non-Cash Investing and Financing Activities	Non-Cash Investing and Financing Activities (all amounts in thousands): Nine Months Ended September 30, 2015 2014 Series A Convertible Preferred stock accrued dividend $ 422 $ 375 Series C Preferred stock accrued dividend 194 41 Issuance of Series D Convertible Preferred stock in connection with debt refinancing 2,751 0 Relative fair value of warrant issued in connection with debt refinancing 42 0 Adjustment to warrant liability upon warrant exercise 0 44 Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP 0 241 Issuance of 242,308 shares to Selway 0 157

DESCRIPTION OF BUSINESS - Addit

DESCRIPTION OF BUSINESS - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Net Income (Loss) Attributable To Parent	$ 1,144	$ (10,273)	$ 3,130	$ (7,675)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total			2,755	1,593
Retained Earnings Accumulated Deficit	(100,460)		(100,460)		$ (103,590)
Stockholders Equity	2,810		2,810		185
Cash	$ 1,631	$ 848	$ 1,631	$ 848	$ 2,358	$ 865

INVENTORIES (Schedule Of Invent

INVENTORIES (Schedule Of Inventories) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Schedule of Inventory [Line Items]
Raw materials	$ 4,702	$ 4,777
Work-in-process	1,833	1,546
Finished goods	1,435	1,503
Inventory, Net	$ 7,970	$ 7,826

DERIVATIVE INSTRUMENTS AND HE31

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Assets and Liabilities) (Detail) $ in Thousands	Sep. 30, 2015USD ($)
Warrant liability [Member] | Warrant [Member]
Derivative Assets (Liabilities), at Fair Value, Net	$ (18)
Currency forward contract [Member] | Other current assets [Member]
Derivative Assets (Liabilities), at Fair Value, Net	$ 0

DERIVATIVE INSTRUMENTS AND HE32

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Additional Information) (Detail)	9 Months Ended
	Sep. 30, 2015
Maximum [Member]
Derivative [Line Items]
Currency forward contract, duration	6 months

CREDIT LINE AND NOTES PAYABLE33

CREDIT LINE AND NOTES PAYABLE (Outstanding Notes Payable) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Promissory Note Payable	$ 645	$ 860
Total	19,911	16,326
Less: Unamortized debt discount	(2,868)	(337)
Less: Current portion of notes payable, including current portion of unamortized debt discount	(655)	(5,775)
Notes payable, net of current portion	16,388	10,214
Monroe Term A Loan [Member]
Bank Loans	17,775	0
Delayed Draw Loan [Member]
Bank Loans	1,491	0
TD Bank Term Loan [Member]
Bank Loans	0	4,239
TD Bank Real Estate Loan [Member]
Bank Loans	0	1,551
Subordinated Term [Member]
Bank Loans	$ 0	$ 9,676

CREDIT LINE AND NOTES PAYABLE34

CREDIT LINE AND NOTES PAYABLE (Additional Information) (Detail) - USD ($)	Aug. 03, 2015	May. 18, 2015	Dec. 31, 2013	Nov. 19, 2013	Jul. 29, 2010	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2010
Notes Payable [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						455,514	455,514
Line of Credit, Current						$ 2,000,000	$ 2,000,000	$ 2,050,000
Amortization of Financing Costs							300,000
Delayed Draw Loan [Member]
Notes Payable [Line Items]
Long-term Debt, Fair Value						$ 2,400,000	$ 2,400,000
Series D Convertible Preferred Stock [Member]
Notes Payable [Line Items]
Preferred Stock Shares Issued						10	10	10
Convertible Preferred Stock, Shares Issued upon Conversion						752,808	752,808
Debt Issuance Cost						$ 400,000
Long-term Debt, Fair Value						2,800,000	$ 2,800,000
Debt Instrument, Unamortized Discount						1,500,000	$ 1,500,000
Monroe Credit Agreement [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date		May 18, 2020
Debt Instrument, Periodic Payment	$ 1,400,000	$ 11,300,000
Debt Instrument, Face Amount		$ 25,000,000
Line of Credit Facility, Interest Rate Description		interest at a rate of the one-month LIBOR plus 9%
Debt Instrument, Term		5 years
Line of Credit Facility, Covenant Terms							a fixed charge coverage ratio of 1.25 to 1.00; (ii) a senior debt to EBITDA ratio of 4.50 to 1.00, decreasing to 1.50 to 1.00 over the term of the loans; and (iii) a twelve month trailing EBITDA, measured quarterly, in the amount of $4,750,000, increasing to $7.0 million over the term of the loans
Line of Credit Facility, Frequency of Payment and Payment Terms							quarterly amortization payments on the last day of each calendar quarter in an aggregate principal amount equal to 0.625% of the original principal amount of the Delayed Draw Loan, increasing to 1.25% on March 31, 2016, and increasing to 2.5% on March 31, 2017, with the balance payable on the maturity date of May 18, 2020.
Line of Credit Facility, Description							$5.0 million and (ii) the sum of 85% of all eligible accounts receivable plus 60% of all eligible inventory
Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid	1,500,000
Debt Issuance Cost	100,000
Debt Instrument, Annual Principal Payment	$ 2,000,000
Monroe Credit Agreement [Member] | Series D Preferred Stock [Member]
Notes Payable [Line Items]
Line of Credit Facility, Interest Rate Description							1
Preferred Stock Shares Issued		10
Convertible Preferred Stock, Shares Issued upon Conversion		752,807.8
Monroe Credit Agreement [Member] | Quarterly Repayments Beginning on June 30, 2015 through March 31, 2016 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		$ 113,000
Monroe Credit Agreement [Member] | Quarterly Repayments Beginning On June 30, 2016 Through March 31, 2017 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		225,000
Monroe Credit Agreement [Member] | Quarterly Repayments Of Beginning on June 30, 2017 through March 31, 2020 [Member]
Notes Payable [Line Items]
Debt Instrument, Periodic Payment		450,000
Monroe Credit Agreement [Member] | Revolving Credit Facility [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		5,000,000
Monroe Credit Agreement [Member] | Secured Debt [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		18,000,000
Monroe Credit Agreement [Member] | Legal Reserve Delayed Draw Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Face Amount		$ 2,000,000
TD Bank [Member]
Notes Payable [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity						5,000,000	$ 5,000,000
Line of Credit Facility, Interest Rate During Period							10.00%
Line of Credit, Current						2,000,000	$ 2,000,000
Line of Credit Facility, Remaining Borrowing Capacity						2,900,000	2,900,000
Promissory Notes Payable [Member]
Notes Payable [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				2.00%
Debt Instrument, Maturity Date				Oct. 15, 2018
Debt Instrument, Periodic Payment				$ 215,000
Debt Instrument, Face Amount				$ 1,075,000
Subordinated Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Maturity Date			Jun. 30, 2016
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			455,514						160,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.01						$ 1.50
Warrants Not Settleable in Cash, Fair Value Disclosure						18,000	18,000
Term Loan [Member]
Notes Payable [Line Items]
Debt Instrument, Unamortized Discount						$ 400,000	$ 400,000
Granite Creek Partners Agent Llc [Member]
Notes Payable [Line Items]
Subordinated Borrowing, Interest Rate					11.00%
Debt Instrument, Maturity Date					Jun. 30, 2016
Debt Instrument Convertible Number Of Equity Instrument					2,666,667
Debt Instrument, Convertible, Conversion Price					$ 3.19
Issuance Of Loan					$ 8,500,000

PREFERRED STOCK (Additional Inf

PREFERRED STOCK (Additional Information) (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended		3 Months Ended	9 Months Ended
	Jul. 30, 2014	Nov. 19, 2013	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014
Series A Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Liquidation Preference Per Share			$ 32.50	$ 32.50
Convertible Preferred Stock, Shares Issued upon Conversion			50	50
Convertible Preferred Stock Conversion Price			$ 0.65	$ 0.65
Conversion Price				$ 0.13664587
Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage				12.00%
Preferred Stock Shares Issued			123,097	123,097	123,097
Series C Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001	$ 0.001
Preferred Stock, Dividend Rate, Percentage				12.00%
Preferred Stock Liquidation Preference Description				each share of Series C Preferred Stock would be entitled to a liquidation preference equal to the sum of: (1) $3,000 per share (the Base Liquidation Value) and the (2) the amount, if any, by which the Base Value exceeds 150% of the purchase price (the Excess Liquidation Value), plus any accrued but unpaid dividends, in each case subject to customary adjustments as set forth in the Amended Series C Certificate of Designation
Preferred Stock Dividend Payable Percentage Of Shares				75.00%
Accrued Dividends Payable In Cash Or In Kind Per Share			$ 2,000	$ 2,000
Preferred Stock Shares Issued			1,000	1,000	1,000
Series B convertible preferred stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001	$ 0.001
Preferred Stock Shares Issued			1,000	1,000	1,000
Series D Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000	1,000,000
Preferred Stock Par Or Stated Value Per Share			$ 0.001	$ 0.001	$ 0.001
Convertible Preferred Stock, Shares Issued upon Conversion			752,808	752,808
Preferred Stock Shares Issued			10	10	10
Proceeds from Issuance of Convertible Preferred Stock			$ 1.9
Debt Instrument, Unamortized Discount			1.5	$ 1.5
Debt Issuance Cost			$ 0.4
Preferred Stock [Member] | Series A Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, New Issues				20
Preferred Stock [Member] | Series C Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, New Issues				0
Preferred Stock [Member] | Series D Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, New Issues				10
Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock Par Or Stated Value Per Share		$ 0.001
Purchase Agreement [Member] | Series B convertible preferred stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock, Conversion Basis				if the Company issues or sells shares of Common Stock or other equity securities for no consideration or for consideration that is based on an equity valuation of the Company of less than $2.0 million in the aggregate (a Trigger Issuance). In the event of a Trigger Issuance, the Conversion Number shall be increased as of the close of business on the effective date of the Trigger Issuance to a number calculated as follows: (i) two-thirds of the Common Stock deemed Outstanding (as defined in the Amended Series A Certificate of Designation) immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000. Each share of Series B Preferred Stock will automatically convert into shares of Common Stock on the tenth anniversary of its original issuance date, at the then-current Conversion Number.
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				35,713.147
Series A Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, Other		123,077
Stock Issued During Period, Value, Other		$ 4
Sale of Stock, Price Per Share		$ 32.50
Series B and C Purchase Agreement [Member] | Series B convertible preferred stock [Member]
Preferred Stock Disclosure [Line Items]
Stock Issued During Period, Shares, Other	1,000
Stock Issued During Period, Value, Other	$ 2
Sale of Stock, Price Per Share	$ 2,000
Preferred Stock Par Or Stated Value Per Share	$ 0.001
Net Proceeds from Sale of Preferred Units Used to Pay Contingent Legal Obligation	$ 1.3
Series B and C Purchase Agreement [Member] | Series C Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]
Preferred Stock Par Or Stated Value Per Share	$ 0.001

STOCKHOLDERS' EQUITY (The Drago

STOCKHOLDERS' EQUITY (The Dragonfly Warrant fair value is estimated using the Black-Scholes pricing model) (Detail) - Dragonfly Warrant [Member]	9 Months Ended
	Sep. 30, 2015$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price of underlying equity	$ 0.05
Exercise price	$ 0.05
Expected term (years)	5 years
Risk-free interest rate	1.50%
Estimated dividend yield	0.00%
Volatility	157.00%

STOCKHOLDERS' EQUITY (Warrants

STOCKHOLDERS' EQUITY (Warrants To Purchase Common Stock Outstanding) (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2015	May. 18, 2015
Class of Warrant or Right [Line Items]
Number of Shares Exercisable Under Warrant	455,514
Granite Creek FlexCap I, L.P [Member]
Class of Warrant or Right [Line Items]
Number of Shares Under Warrant	267,950
Number of Shares Exercisable Under Warrant	267,950
Exercise Price	$ 0.01
Expiration Date	Nov. 19, 2023
Patriot Capital II, L.P [Member]
Class of Warrant or Right [Line Items]
Number of Shares Under Warrant	187,564
Number of Shares Exercisable Under Warrant	187,564
Exercise Price	$ 0.01
Expiration Date	Nov. 19, 2023
Dragonfly Capital Partners, LLC [Member]
Class of Warrant or Right [Line Items]
Number of Shares Under Warrant	1,003,744
Number of Shares Exercisable Under Warrant	1,003,744	1,003,744
Exercise Price	$ 0.05	$ 0.05
Expiration Date	May 18, 2020

STOCKHOLDERS' EQUITY (Granite a

STOCKHOLDERS' EQUITY (Granite and Patriot Warrants is estimated using the Black-Scholes pricing model) (Detail) - Granite and Patriot Warrants [Member]	9 Months Ended
	Sep. 30, 2015$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price of underlying equity	$ 0.04
Exercise price	$ 0.01
Expected term (years)	8 years 1 month 6 days
Risk-free interest rate	1.90%
Estimated dividend yield	0.00%
Volatility	165.20%

STOCKHOLDERS' EQUITY (Change In

STOCKHOLDERS' EQUITY (Change In The Fair Value Of The Warrants Liability) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Class of Warrant or Right [Line Items]
Change in fair value of warrants	$ 12	$ (197)	$ 7	$ 4,844
Granite and Patriot Warrants [Member]
Class of Warrant or Right [Line Items]
Warrant liability at December 31, 2014			25
Change in fair value of warrants			(7)
Warrant liability at September 30, 2015	$ 18		$ 18

STOCKHOLDERS' EQUITY (Additiona

STOCKHOLDERS' EQUITY (Additional Information) (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	May. 18, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2012
Stockholders Equity Additional Information [Line Items]
Common stock, shares authorized		150,000,000		150,000,000		150,000,000
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights		455,514		455,514
Fair Value Adjustment of Warrants		$ (12,000)	$ 197,000	$ (7,000)	$ (4,844,000)
Dragonfly Warrant [Member]
Stockholders Equity Additional Information [Line Items]
Fair Value Adjustment of Warrants				$ 46,000
Dragonfly Capital Partners, LLC [Member]
Stockholders Equity Additional Information [Line Items]
Debt Issuance Cost	$ 820,000
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights	1,003,744	1,003,744		1,003,744
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.05	$ 0.05		$ 0.05
Monroe Warrant [Member]
Stockholders Equity Additional Information [Line Items]
Fair Value Adjustment of Warrants				$ 42,000
Subordinated Term Loan [Member]
Stockholders Equity Additional Information [Line Items]
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights		455,514		455,514
Subordinated Term Loan [Member] | Senior Amendment [Member]
Stockholders Equity Additional Information [Line Items]
Class of Warrant or Right, Outstanding							160,000

INCOME TAXES (Additional Inform

INCOME TAXES (Additional Information) (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Current Foreign Tax Expense (Benefit)	$ 211,000	$ 269,000
Deferred Tax Assets, Valuation Allowance, Noncurrent	13,100,000
Current State and Local Tax Expense (Benefit)	$ 70,000

RELATED PARTY TRANSACTIONS (Add

RELATED PARTY TRANSACTIONS (Additional Information) (Detail) - USD ($)	1 Months Ended	9 Months Ended
	May. 18, 2015	Sep. 30, 2015	Nov. 19, 2013	Dec. 31, 2012
Jfc [Member]
Related Party Transaction [Line Items]
Unsecured Debt				$ 2,100,000
Amended JFC Note [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Debt Instrument, Convertible, Conversion Price			$ 32.50
Convertible Debt			$ 1,000,000
Repayments of Related Party Debt	$ 2,100,000
Repayments Of Related Party Debt, Accrued interest	500,000
James Schleck [Member] | Series A Preferred Stock [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 650
Debt Conversion, Converted Instrument, Shares Issued	20
Cyalume Specialty Products Inc [Member]
Related Party Transaction [Line Items]
Monthly Lease Payments Due To Related Parties		$ 30,000
Lease Expiration Date		Aug. 31, 2016

NET INCOME (LOSS) PER COMMON 43

NET INCOME (LOSS) PER COMMON SHARE (Net Income (Loss) Per Common Share) (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator
Net income (loss)	$ 1,144	$ (10,273)	$ 3,130	$ (7,675)
Income (loss) available to common stockholders - basic	931	(15,365)	2,514	(13,012)
Effect of dilutive securities:
Less: Change in fair value of warrant liability for dilutive warrants (income) expense	(12)	0	(7)	0
Dilutive Securities Effect On Basic Earnings Per Share Other	0	0	45	0
Income (loss) available to common stockholders - diluted	$ 1,065	$ (15,365)	$ 2,974	$ (13,012)
Denominator:
Weighted average shares outstanding - basic	21,400,244	21,400,244	21,400,244	21,258,011
Effect of dilutive securities:
Warrants	744,256	0	581,133	0
Convertible debt	0	0	0	0
Weighted average common shares - diluted	101,875,913	21,400,244	101,579,116	21,258,011
Income (loss) per common share:
Basic	$ 0.04	$ (0.72)	$ 0.12	$ (0.61)
Diluted	$ 0.01	$ (0.72)	$ 0.03	$ (0.61)
Related Party Promissory Note [Member]
Effect of dilutive securities:
Dilutive Securities Effect On Basic Earnings Per Share Other	$ 0	$ 0	$ 45	$ 0
Effect of dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	0	0	3,699,303	0
Series A Convertible Preferred Stock [Member]
Numerator
Less: Preferred Stock Dividends, Income Statement Impact	$ (146)	$ (130)	$ (422)	$ (375)
Effect of dilutive securities:
Dilutive Securities Effect On Basic Earnings Per Share Other	$ 146	$ 0	$ 422	$ 0
Effect of dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	36,490,188	0	36,490,188	0
Series C preferred stock dividends [Member]
Numerator
Less: Preferred Stock Dividends, Income Statement Impact	$ (67)	$ (41)	$ (194)	$ (41)
Series B convertible preferred stock
Effect of dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	35,713,147	0	35,713,147	0
Series D convertible preferred stock [Member]
Effect of dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock	7,528,078	0	3,695,101	0
Series A Deemed Dividend [Member]
Numerator
Less: Preferred Stock Dividends, Income Statement Impact	$ 0	$ (2,422)	$ 0	$ (2,422)
Series B Deemed Dividend [Member]
Numerator
Less: Preferred Stock Dividends, Income Statement Impact	0	(1,098)	0	(1,098)
Series C Deemed Dividend [Member]
Numerator
Less: Preferred Stock Dividends, Income Statement Impact	$ 0	$ (1,401)	$ 0	$ (1,401)

NET INCOME (LOSS) PER COMMON 44

NET INCOME (LOSS) PER COMMON SHARE (Dilutive Common Share Equivalents Were Excluded From The Calculation Of Diluted Net Income Per Common Share) (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	10,505,322	2,636,186	10,505,322	2,636,186
Series A convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	0	32,421,014	0	32,421,014
Series B convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	0	35,713,147	0	35,713,147
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	0	455,514	0	455,514
Convertible related party promissory note [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	0	7,318,187	0	7,318,187
Convertible Debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from the calculation of diluted net income per common share	0	2,666,667	0	2,666,667

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Additional Information) (Detail) - USD ($)	1 Months Ended	9 Months Ended
	Jul. 18, 2011	Sep. 30, 2015	Oct. 10, 2016	Jan. 10, 2016	Nov. 19, 2013
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Settlement Agreement, Terms		Pursuant to the Omniglow Settlement Agreement, CTI agreed to either pay the full settlement amount of approximately $4.5 million or satisfy the settlement amount as follows: (i) an initial payment of $250,000, (ii) transfer the 625,139 Escrowed Shares, (iii) payment of $1.0 million in cash within 21 days from the execution of the Omniglow Settlement Agreement and (iv) additional payments in cash and/or through cooperative marketing credits of $1.9 million if paid within 18 months from the date of the Omniglow Settlement Agreement, or of approximately $2.4 million if paid within 27 months from the date of the Omniglow Settlement Agreement
Escrow Shares Fair Value					625,139
Reduced Final Payment		$ 1,400,000
Legal obligation reversed		1,381,000
Subsequent Event [Member]
Commitments and Contingencies Disclosure [Line Items]
Election payment			$ 2,350,000
Reduced Final Payment in Lieu of a Payment				$ 1,900,000
CTI [Member]
Commitments and Contingencies Disclosure [Line Items]
Reduced Final Payment		$ 1,400,000
Omniglow [Member]
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Damages Awarded, Value	$ 2,600,000
Prejudgment Interest Rate	12.00%
Loss contingency damages awarded accrued interest	$ 1,300,000
Omniglow [Member] | Attorney Fees and Costs [Member]
Commitments and Contingencies Disclosure [Line Items]
Loss Contingency, Damages Awarded, Value	$ 235,000
Prejudgment Interest Rate	12.00%

FAIR VALUES OF ASSETS AND LIA46

FAIR VALUES OF ASSETS AND LIABILITIES (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015		Dec. 31, 2014
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	$ (18)		$ (25)
Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	(18)	[1]	(25)	[2]
Level 1 Quoted Prices in Active Markets for Identical Assets [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0		0
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	0	[2]
Level 2 Significant Other Observable Inputs [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0		0
Level 2 Significant Other Observable Inputs [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	0	[2]
Level 3 Significant Unobservable Inputs [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	(18)		(25)
Level 3 Significant Unobservable Inputs [Member] | Warrants [Member]
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring Basis	$ (18)	[1]	$ (25)	[2]
[1]	The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
[2]	The Company has classified its warrant liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model (See Note 8 for assumptions).

SUPPLEMENTAL DISCLOSURE OF CA47

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Cash Paid for Interest and Income Taxes) (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Interest	$ 1,019	$ 456
Income taxes	$ 655	$ 171

SUPPLEMENTAL DISCLOSURE OF CA48

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Non-Cash Investing and Financing Activities) (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Non-Cash Investing And Financing Activities [Line Items]
Relative fair value of warrant issued in connection with debt refinancing	$ 42	$ 0
Adjustment to warrant liability upon warrant exercise	0	44
Selway [Member]
Non-Cash Investing And Financing Activities [Line Items]
Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP	0	157
Series A Convertible Preferred stock accrued dividend [Member]
Non-Cash Investing And Financing Activities [Line Items]
Preferred stock dividends	422	375
Series C Preferred stock accrued dividend [Member]
Non-Cash Investing And Financing Activities [Line Items]
Preferred stock dividends	194	41
Series D Preferred Stock [Member]
Non-Cash Investing And Financing Activities [Line Items]
Shares Issued During the Period Connection With Debt Refinancing	2,751	0
Cyalume Specialty Products [Member]
Non-Cash Investing And Financing Activities [Line Items]
Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP	$ 0	$ 241

SUPPLEMENTAL DISCLOSURE OF CA49

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Non-Cash Investing and Financing Activities) (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2015shares
Selway Capital, LLC [Member]
Non-Cash Investing And Financing Activities [Line Items]
Stock Issued During Period, Shares, New Issues	242,308
Cyalume Specialty Products [Member]
Non-Cash Investing And Financing Activities [Line Items]
Stock Issued During Period Shares Contingent Consideration Liability	350,000